Established at the end of 2020, TTM Capital is a professional investment firm focusing on early and growth-stage investments in the life science and healthcare sectors.

We focus on selective and exceptional investment opportunities in biopharmaceuticals, medical devices, in vitro diagnostics, and “medical+”, driven by cutting-edge technologies. In such rigorous approach, we concentrate on niche markets with significant advantages, and pay close attention to the "unmet needs" of the global medical market and patients.

Our team has been deeply involved in the medical and biotechnology sectors for many years, with extensive backgrounds in medical investments for years at top investment funds and over decades of experience in the entire industrial chain of leading global pharmaceutical companies.

We always adhere to our original aspirations, focus on the long term, navigate through cycles, equip with global perspective, and build an efficient ecosystem that integrates dots seamlessly across capital, enterprises, spaces, academia, talents, and projects. We persistently empower invested companies and create synergy, jointly promote medical innovation, and benefit society in return.

Comprehensive linkage: Linking the core resources of the medical industry, schools, government, and investment, complementing and empowering each other, achieving mutual success.

Multi-disciplinary sourcing: Leverage the fund's professional advantages, and create ventures together with technical experts and business talents, enhance the possibility of investing in unicorns. 

Strategic alliance: United effort with determined co-operation, with common aspirations, to achieve long-term win-win.